Skip to main content
Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · IEX Real-Time Price · USD
2.130
+0.080 (3.90%)
At close: Apr 26, 2024, 4:00 PM
2.090
-0.040 (-1.88%)
After-hours: Apr 26, 2024, 5:05 PM EDT

Poseida Therapeutics Revenue

In the year 2023, Poseida Therapeutics had annual revenue of $64.70M, a decrease of -50.42%. Revenue in the quarter ending December 31, 2023 was $25.00M with 148.68% year-over-year growth.

Revenue (ttm)
$64.70M
Revenue Growth
-50.42%
P/S Ratio
3.18
Revenue / Employee
$196,070
Employees
330
Market Cap
205.52M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202364.70M-65.79M-50.42%
Dec 31, 2022130.49M99.25M317.73%
Dec 31, 202131.24M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rigel Pharmaceuticals 116.88M
Codexis 70.14M
Innate Pharma 68.49M
Zevra Therapeutics 27.46M
Lineage Cell Therapeutics 8.95M
Revenue Rankings

PSTX News

More News